Discover

APYX
Apyx Medical Corporation
4.66
2 x 3.37
2 x 5.76
bid
ask
+
0.17
3.79%
2 @ 04:00 PM
4.66 +0.00 (0.00%)
Ytd33.14%
1y108.04%
4.45
day range
4.77
1.59
52 week range
5.08
Open4.45Prev Close4.49Low4.45High4.77Mkt Cap196.23M
Vol78.30KAvg Vol179.54KEPS-0.22P/EN/AForward P/E-3.39
Beta1.21Short Ratio5.49Inst. Own40.43%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg4.01200-d Avg3.641yr Est2.83
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-082024-09-0.15-0.140.016.67%
2024-08-082024-06-0.18-0.19-0.01-5.56%
2024-05-092024-03-0.18-0.22-0.04-22.22%
2024-03-212023-12-0.13-0.19-0.06-46.15%
2023-11-092023-09-0.1-0.13-0.03-30.00%
2023-08-102023-06-0.12-0.110.018.33%
Upgrade / Downgrade
DateFirmActionFromTo
2024-10-17BTIGUpgradeNeutral
2024-09-16JMP SecuritiesUpgradeMarket Perform
2023-11-10Stephens & Co.UpgradeOverweightOverweight
2023-08-11Piper SandlerUpgradeOverweightOverweight
2023-07-14Stephens & Co.UpgradeOverweight
2023-06-15Lake StreetUpgradeBuy
Profile
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Insider Holder
DateNameRelationQuantityDescription
2023-06-05GERAGHTY MICHAEL EDirector27.50KConversion of Exercise of derivative security
2023-11-13GOODWIN CHARLES D IIChief Executive Officer90.00KPurchase
2024-08-12HILL MATTHEW CChief Financial Officer7.84KPurchase
2023-06-25HORNSBY TODDOfficer40.00Conversion of Exercise of derivative security
2023-07-11WALDMAN LAWRENCE JDirector0.00Conversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Archon Capital Management LLC3.12M5.49M8.28%
2024-09-29Royce & Associates LP2.58M4.55M6.86%
2024-09-29Vanguard Group Inc1.48M2.61M3.93%
2024-09-29Horizon Kinetics Asset Management LLC615.00K1.08M1.63%
2024-09-29Taylor Frigon Capital Management LLC596.88K1.05M1.59%
2024-09-29Silverberg Bernstein Capital Management LLC 572.63K1.01M1.52%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29Vanguard Total Stock Market Index Fund1.02M1.79M2.70%
2024-09-29Royce Small-Cap Opportunity Fund1.00M1.77M2.67%
2024-09-29Royce Micro-Cap Fund615.22K1.09M1.63%
2024-09-29RENN Fund, Inc.615.00K1.08M1.63%
2024-09-29Vanguard Extended Market Index Fund414.66K731.38K1.10%
2024-09-29Royce Capital Fund-Micro-Cap Portfolio270.27K476.71K0.72%